Charles River Laboratories International, Inc.
CRLLast close · Oct 16, 2026300.15−6.09 (−1.99%)
Market cap$14.5B
Of the 85 managers this site tracks, 2 held Charles River Laboratories (CRL) at the end of Q2 2026, their latest 13Fs. The largest position by value was Bill Nygren's, $508.3M; John Rogers's ($341.6M) follows. No Schedule 13D or 13G is on file for CRL from the activists and large holders the site follows.
Superinvestors holding CRL
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Bill Nygren | Harris Associates L P | Q2 2026 | 2M | $508.3M |
| John Rogers | Ariel Investments, LLC | Q2 2026 | 2M | $341.6M |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.